Researcher profile

Tianxi Cai

Tianxi Cai contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
9works
0followers
7topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

9 published item(s)

preprint2026arXiv

Toward Global Large Language Models in Medicine

Despite continuous advances in medical technology, the global distribution of health care resources remains uneven. The development of large language models (LLMs) has transformed the landscape of medicine and holds promise for improving health care quality and expanding access to medical information globally. However, existing LLMs are primarily trained on high-resource languages, limiting their applicability in global medical scenarios. To address this gap, we constructed GlobMed, a large multilingual medical dataset, containing over 500,000 entries spanning 12 languages, including four low-resource languages. Building on this, we established GlobMed-Bench, which systematically assesses 56 state-of-the-art proprietary and open-weight LLMs across multiple multilingual medical tasks, revealing significant performance disparities across languages, particularly for low-resource languages. Additionally, we introduced GlobMed-LLMs, a suite of multilingual medical LLMs trained on GlobMed, with parameters ranging from 1.7B to 8B. GlobMed-LLMs achieved an average performance improvement of over 40% relative to baseline models, with a more than threefold increase in performance on low-resource languages. Together, these resources provide an important foundation for advancing the equitable development and application of LLMs globally, enabling broader language communities to benefit from technological advances.

preprint2023arXiv

Robust Inference for Federated Meta-Learning

Synthesizing information from multiple data sources is critical to ensure knowledge generalizability. Integrative analysis of multi-source data is challenging due to the heterogeneity across sources and data-sharing constraints due to privacy concerns. In this paper, we consider a general robust inference framework for federated meta-learning of data from multiple sites, enabling statistical inference for the prevailing model, defined as the one matching the majority of the sites. Statistical inference for the prevailing model is challenging since it requires a data-adaptive mechanism to select eligible sites and subsequently account for the selection uncertainty. We propose a novel sampling method to address the additional variation arising from the selection. Our devised CI construction does not require sites to share individual-level data and is shown to be valid without requiring the selection of eligible sites to be error-free. The proposed robust inference for federated meta-learning (RIFL) methodology is broadly applicable and illustrated with three inference problems: aggregation of parametric models, high-dimensional prediction models, and inference for average treatment effects. We use RIFL to perform federated learning of mortality risk for patients hospitalized with COVID-19 using real-world EHR data from 16 healthcare centers representing 275 hospitals across four countries.

preprint2022arXiv

Augmented Transfer Regression Learning with Semi-non-parametric Nuisance Models

In contemporary statistical learning, covariate shift correction plays an important role in transfer learning when distribution of the testing data is shifted from the training data. Importance weighting, as a natural and principle strategy to adjust for covariate shift, has been commonly used in the field of transfer learning. However, this strategy is not robust to model misspecification or excessive estimation error. In this paper, we propose an augmented transfer regression learning (ATReL) approach that introduces an imputation model for the targeted response, and uses it to augment the importance weighting equation. With novel semi-non-parametric constructions and calibrated moment estimating equations for the two nuisance models, our ATReL method is less prone to (i) the curse of dimensionality compared to nonparametric approaches, and (ii) model mis-specification than parametric approaches. We show that our ATReL estimator is root-n-consistent when at least one nuisance model is correctly specified, estimation for the parametric part of the nuisance models achieves parametric rate, and the nonparametric components are rate doubly robust. Simulation studies demonstrate that our method is more robust and efficient than existing parametric and fully nonparametric (machine learning) estimators under various configurations. We also examine the utility of our method through a real example about transfer learning of phenotyping algorithm for rheumatoid arthritis across different time windows. Finally, we propose ways to enhance the intrinsic efficiency of our estimator and to incorporate modern machine learning methods with our proposed framework.

preprint2022arXiv

Multimodal Learning on Graphs for Disease Relation Extraction

Objective: Disease knowledge graphs are a way to connect, organize, and access disparate information about diseases with numerous benefits for artificial intelligence (AI). To create knowledge graphs, it is necessary to extract knowledge from multimodal datasets in the form of relationships between disease concepts and normalize both concepts and relationship types. Methods: We introduce REMAP, a multimodal approach for disease relation extraction and classification. The REMAP machine learning approach jointly embeds a partial, incomplete knowledge graph and a medical language dataset into a compact latent vector space, followed by aligning the multimodal embeddings for optimal disease relation extraction. Results: We apply REMAP approach to a disease knowledge graph with 96,913 relations and a text dataset of 1.24 million sentences. On a dataset annotated by human experts, REMAP improves text-based disease relation extraction by 10.0% (accuracy) and 17.2% (F1-score) by fusing disease knowledge graphs with text information. Further, REMAP leverages text information to recommend new relationships in the knowledge graph, outperforming graph-based methods by 8.4% (accuracy) and 10.4% (F1-score). Conclusion: REMAP is a multimodal approach for extracting and classifying disease relationships by fusing structured knowledge and text information. REMAP provides a flexible neural architecture to easily find, access, and validate AI-driven relationships between disease concepts.

preprint2021arXiv

Risk Prediction with Imperfect Survival Outcome Information from Electronic Health Records

Readily available proxies for time of disease onset such as time of the first diagnostic code can lead to substantial risk prediction error if performing analyses based on poor proxies. Due to the lack of detailed documentation and labor intensiveness of manual annotation, it is often only feasible to ascertain for a small subset the current status of the disease by a follow up time rather than the exact time. In this paper, we aim to develop risk prediction models for the onset time efficiently leveraging both a small number of labels on current status and a large number of unlabeled observations on imperfect proxies. Under a semiparametric transformation model for onset and a highly flexible measurement error models for proxy onset time, we propose the semisupervised risk prediction method by combining information from proxies and limited labels efficiently. From an initial estimator solely based on the labelled subset, we perform a one-step correction with the full data augmenting against a mean zero rank correlation score derived from the proxies. We establish the consistency and asymptotic normality of the proposed semi-supervised estimator and provide a resampling procedure for interval estimation. Simulation studies demonstrate that the proposed estimator performs well in finite sample. We illustrate the proposed estimator by developing a genetic risk prediction model for obesity using data from Partners Biobank Electronic Health Records (EHR).

preprint2021arXiv

Semi-Supervised Off Policy Reinforcement Learning

Reinforcement learning (RL) has shown great success in estimating sequential treatment strategies which take into account patient heterogeneity. However, health-outcome information, which is used as the reward for reinforcement learning methods, is often not well coded but rather embedded in clinical notes. Extracting precise outcome information is a resource intensive task, so most of the available well-annotated cohorts are small. To address this issue, we propose a semi-supervised learning (SSL) approach that efficiently leverages a small sized labeled data with true outcome observed, and a large unlabeled data with outcome surrogates. In particular, we propose a semi-supervised, efficient approach to Q-learning and doubly robust off policy value estimation. Generalizing SSL to sequential treatment regimes brings interesting challenges: 1) Feature distribution for Q-learning is unknown as it includes previous outcomes. 2) The surrogate variables we leverage in the modified SSL framework are predictive of the outcome but not informative to the optimal policy or value function. We provide theoretical results for our Q-function and value function estimators to understand to what degree efficiency can be gained from SSL. Our method is at least as efficient as the supervised approach, and moreover safe as it robust to mis-specification of the imputation models.

preprint2020arXiv

Individual Data Protected Integrative Regression Analysis of High-dimensional Heterogeneous Data

Evidence-based decision making often relies on meta-analyzing multiple studies, which enables more precise estimation and investigation of generalizability. Integrative analysis of multiple heterogeneous studies is, however, highly challenging in the ultra high dimensional setting. The challenge is even more pronounced when the individual level data cannot be shared across studies, known as DataSHIELD constraint (Wolfson et al., 2010). Under sparse regression models that are assumed to be similar yet not identical across studies, we propose in this paper a novel integrative estimation procedure for data-Shielding High-dimensional Integrative Regression (SHIR). SHIR protects individual data through summary-statistics-based integrating procedure, accommodates between study heterogeneity in both the covariate distribution and model parameters, and attains consistent variable selection. Theoretically, SHIR is statistically more efficient than the existing distributed approaches that integrate debiased LASSO estimators from the local sites. Furthermore, the estimation error incurred by aggregating derived data is negligible compared to the statistical minimax rate and SHIR is shown to be asymptotically equivalent in estimation to the ideal estimator obtained by sharing all data. The finite-sample performance of our method is studied and compared with existing approaches via extensive simulation settings. We further illustrate the utility of SHIR to derive phenotyping algorithms for coronary artery disease using electronic health records data from multiple chronic disease cohorts.

preprint2020arXiv

Integrative High Dimensional Multiple Testing with Heterogeneity under Data Sharing Constraints

Identifying informative predictors in a high dimensional regression model is a critical step for association analysis and predictive modeling. Signal detection in the high dimensional setting often fails due to the limited sample size. One approach to improve power is through meta-analyzing multiple studies on the same scientific question. However, integrative analysis of high dimensional data from multiple studies is challenging in the presence of between study heterogeneity. The challenge is even more pronounced with additional data sharing constraints under which only summary data but not individual level data can be shared across different sites. In this paper, we propose a novel data shielding integrative large-scale testing (DSILT) approach to signal detection by allowing between study heterogeneity and not requiring sharing of individual level data. Assuming the underlying high dimensional regression models of the data differ across studies yet share similar support, the DSILT approach incorporates proper integrative estimation and debiasing procedures to construct test statistics for the overall effects of specific covariates. We also develop a multiple testing procedure to identify significant effects while controlling for false discovery rate (FDR) and false discovery proportion (FDP). Theoretical comparisons of the DSILT procedure with the ideal individual--level meta--analysis (ILMA) approach and other distributed inference methods are investigated. Simulation studies demonstrate that the DSILT procedure performs well in both false discovery control and attaining power. The proposed method is applied to a real example on detecting interaction effect of the genetic variants for statins and obesity on the risk for Type 2 Diabetes.

preprint2020arXiv

Optimal Statistical Inference for Individualized Treatment Effects in High-dimensional Models

The ability to predict individualized treatment effects (ITEs) based on a given patient's profile is essential for personalized medicine. We propose a hypothesis testing approach to choosing between two potential treatments for a given individual in the framework of high-dimensional linear models. The methodological novelty lies in the construction of a debiased estimator of the ITE and establishment of its asymptotic normality uniformly for an arbitrary future high-dimensional observation, while the existing methods can only handle certain specific forms of observations. We introduce a testing procedure with the type-I error controlled and establish its asymptotic power. The proposed method can be extended to making inference for general linear contrasts, including both the average treatment effect and outcome prediction. We introduce the optimality framework for hypothesis testing from both the minimaxity and adaptivity perspectives and establish the optimality of the proposed procedure. An extension to high-dimensional approximate linear models is also considered. The finite sample performance of the procedure is demonstrated in simulation studies and further illustrated through an analysis of electronic health records data from patients with rheumatoid arthritis.